These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 19130459)
1. Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer. Guler G; Huebner K; Himmetoglu C; Jimenez RE; Costinean S; Volinia S; Pilarski RT; Hayran M; Shapiro CL Cancer; 2009 Feb; 115(4):899-908. PubMed ID: 19130459 [TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features. Guler G; Himmetoglu C; Jimenez RE; Geyer SM; Wang WP; Costinean S; Pilarski RT; Morrison C; Suren D; Liu J; Chen J; Kamal J; Shapiro CL; Huebner K Breast Cancer Res Treat; 2011 Sep; 129(2):421-32. PubMed ID: 21069451 [TBL] [Abstract][Full Text] [Related]
3. Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features. Bloomston M; Kneile J; Butterfield M; Dillhoff M; Muscarella P; Ellison EC; Melvin WS; Croce CM; Pichiorri F; Huebner K; Frankel WL Ann Surg Oncol; 2009 Aug; 16(8):2331-8. PubMed ID: 19434452 [TBL] [Abstract][Full Text] [Related]
4. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland. Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354 [TBL] [Abstract][Full Text] [Related]
5. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846 [TBL] [Abstract][Full Text] [Related]
6. Expression of fragile histidine triad (FHIT) and WW-domain oxidoreductase gene (WWOX) in nasopharyngeal carcinoma. Chen X; Li P; Yang Z; Mo WN Asian Pac J Cancer Prev; 2013; 14(1):165-71. PubMed ID: 23534718 [TBL] [Abstract][Full Text] [Related]
8. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866 [TBL] [Abstract][Full Text] [Related]
9. Concordant loss of fragile gene expression early in breast cancer development. Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374 [TBL] [Abstract][Full Text] [Related]
10. Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX. Ishii H; Mimori K; Vecchione A; Sutheesophon K; Fujiwara T; Mori M; Furukawa Y Biochem Biophys Res Commun; 2004 Apr; 316(4):1088-93. PubMed ID: 15044096 [TBL] [Abstract][Full Text] [Related]
11. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Cheang MC; Voduc D; Bajdik C; Leung S; McKinney S; Chia SK; Perou CM; Nielsen TO Clin Cancer Res; 2008 Mar; 14(5):1368-76. PubMed ID: 18316557 [TBL] [Abstract][Full Text] [Related]
12. Wwox and Ap2gamma expression levels predict tamoxifen response. Guler G; Iliopoulos D; Guler N; Himmetoglu C; Hayran M; Huebner K Clin Cancer Res; 2007 Oct; 13(20):6115-21. PubMed ID: 17947476 [TBL] [Abstract][Full Text] [Related]
13. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35. Nassar A; Sussman ZM; Lawson D; Cohen C Breast J; 2012 Sep; 18(5):399-405. PubMed ID: 22882580 [TBL] [Abstract][Full Text] [Related]
14. A novel approach to simultaneously scan genes at fragile sites. Willem P; Brown J; Schouten J BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604 [TBL] [Abstract][Full Text] [Related]
15. [Roles of immunohistochemistry in prognostic assessment of basal-like breast cancer]. Liu H; Fan QH; Zhang ZH; Li X; Yu HP; Liu GZ; Meng FQ Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):23-8. PubMed ID: 19489221 [TBL] [Abstract][Full Text] [Related]
16. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328 [TBL] [Abstract][Full Text] [Related]
17. A subset of breast cancer predisposes to brain metastasis. Shao MM; Liu J; Vong JS; Niu Y; Germin B; Tang P; Chan AW; Lui PC; Law BK; Tan PH; Tse GM Med Mol Morphol; 2011 Mar; 44(1):15-20. PubMed ID: 21424932 [TBL] [Abstract][Full Text] [Related]
18. [Expression of BRCA1 and WWOX and their clinicopathologic implication in breast carcinomas occurring in young women]. Zhang QL; Zhang QH; Cong H; Zhang XL Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):90-4. PubMed ID: 23710914 [TBL] [Abstract][Full Text] [Related]